← Open Payments lookup

LYNDSAY HAFFERTY: Open Payments

NPI 1477945095 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$586 in 29 payments from 8 companies in 2025. Trend: 2023 $220 · 2024 $182 · 2025 $586

Food & beverage: $586
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$166
ABBVIE INC.9$143
Abbott Laboratories6$107
Dexcom, Inc.3$54
Novo Nordisk Inc3$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Astellas Pharma US Inc1$23
Aimmune Therapeutics, Inc.1$14

Products named: AIRSUPRA, FREESTYLE LIBRE 3, QULIPTA, Dexcom G6 Transmitter, VRAYLAR, CAPLYTA, Ozempic, Veozah.

Industry payments across AZ — which companies pay providers there.